The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: A comprehensive meta-analysis

American Heart Journal

Volumn 165, Issue 5, 2013, Pages 679-692

  Romeo, Francesco ^a   Acconcia, Maria Cristina ^b   Sergi, Domenico ^a   Romeo, Alessia ^b   Muscoli, Saverio ^b   Valente, Serafina ^c   Gensini, Gian Franco ^c   Chiarotti, Flavia ^d   Caretta, Quintilio ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ATTRIBUTABLE RISK; BLEEDING; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY RECANALIZATION; FIBRINOLYTIC THERAPY; HUMAN; INTRAAORTIC BALLOON PUMP; LONG TERM SURVIVAL; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION; REVIEW; RISK ASSESSMENT; SAFETY; SYSTEMATIC REVIEW;

HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84876814456     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.02.020     Document Type: Review

References (44)

1. TRIUMPH Investigators, J.H. Alexander, and H.R. Reynolds Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial JAMA 297 2007 1657 1666
2. R.J. Goldberg, F.A. Spencer, and J.M. Gore Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective Circulation 119 2009 1211 1219
3. T. Thom, N. Haase, and W. Rosamond American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 113 2006 e85 e151
4. H. Thiele, and G. Schuler Cardiogenic shock: to pump or not to pump? Eur Heart J 30 2009 389 390
5. H. Thiele, B. Allam, and G. Chatellier Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 31 2010 1828 1835
6. R. Prondzinsky, S. Unverzagt, and M. Russ Hemodynamic Effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomised IABP Shock Trial Shock 37 2012 378 384
7. M. Buerke, H. Lemm, and S. Dietz Pathophysiology, diagnosis, and treatment of infarction-related cardiogenic shock Herz 36 2011 73 83
8. J.S. Hochman, L.A. Sleeper, and J.G. Webb Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction JAMA 295 2006 2511 2515
9. P.T. O'Gara, F.G. Kushner, and D.D. Ascheim 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 2013 e362 e425
10. G. Steg, S.K. James, and D. Atar The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
11. E.M. Antman, D.T. Anbe, and P.W. Armstrong American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction Circulation 110 2004 588 636
12. E.M. Antman, M. Hand, and P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
13. F. Van de Werf, J. Bax, and A. Betriu ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
14. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), W. Wijns, and P. Kolh Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
15. S. Moulopoulos, S. Stamatelopoulos, and P. Petrou Intraaortic balloon assistance in intractable cardiogenic shock Eur Heart J 7 1986 396 403
16. T.A. Sanborn, L.A. Sleeper, and E.R. Bates Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36 3 Suppl A 2000 1123 1129
17. E.M. Ohman, J. Nanas, and R.J. Stomel TACTICS Trial. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial J Thromb Thrombolysis 19 2005 33 39
18. R.D. Anderson, E.M. Ohman, and D.R. Holmes Jr. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries J Am Coll Cardiol 30 1997 708 715
19. H.V. Barron, N.R. Every, and L.S. Parsons Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2 Am Heart J 141 2001 933 939
20. J.R. Bengtson, A.J. Kaplan, and K.S. Pieper Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era J Am Coll Cardiol 20 1992 1482 1489
21. P.J. Kovack, M.A. Rasak, and E.R. Bates Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock J Am Coll Cardiol 29 1997 1454 1458
22. R.J. Stomel, M. Rasak, and E.R. Bates Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital Chest 105 1994 997 1002
23. R. Waksman, A.T. Weiss, and M.S. Gotsman Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction Eur Heart J 14 1993 71 74
24. H. Thiele, U. Zeymer, and F.J. Neumann IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock N Engl J Med 367 2012 1287 1296
25. U. Zeymer, M. Hochadel, and K.E. Hauptmann Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry Clin Res Cardiol 102 2012 223 227
26. K.D. Sjauw, A.E. Engström, and M.M. Vis A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30 2009 459 468
27. A. Bahekar, M. Singh, and S. Singh Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis J Cardiovasc Pharmacol Ther 17 2012 44 56
28. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
29. J.S. Hochman, L.A. Sleeper, and J.G. Webb Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock N Engl J Med 341 1999 625 634
30. S. Unverzagt, M.T. Machemer, and A. Solms Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock Cochrane Database Syst Rev 6 2011 CD007398
31. S. Cassese, A. de Waha, and G. Ndrepepa Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials Am Heart J 164 2012 58 65
32. J.M. Cheng, C.A. den Uil, and S.E. Hoeks Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials Eur Heart J 30 2009 2102 2108
33. Review Manager (RevMan) [Computer program] Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2011.
34. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011 http://www.cochrane-handbook.org
35. U. Zeymer, T. Bauer, and C. Hamm Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI EuroIntervention 7 2011 437 441
36. J. Gu, W. Hu, and H. Xiao Intra-aortic balloon pump improves clinical prognosis and attenuates C-reactive protein level in acute STEMI complicated by cardiogenic shock Cardiology 117 2010 75 80
37. D.A. Stub, W. Chan, and D.J. Clark Are intra-aortic balloon pumps harmful in cardiogenic shock? Eur Heart J 32 Abstract Supplement 2011 723 Poster text http://spo.escardio.org/eslides/view.aspx?eevtid=48&fp=P4162 last access on July 3rd 2012
38. M.M. Vis, K.D. Sjauw, and R.J. van der Schaaf In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes Am Heart J 154 2007 1184 1190
39. M.M. Vis, K.D. Sjauw, and R.J. van der Schaaf Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock Am J Cardiol 99 2007 1201 1202
40. R. Prondzinsky, H. Lemm, and M. Swyter Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome Crit Care Med 38 2010 152 160
41. J.K. French, H.A. Feldman, and S.F. Assmann SHOCK Investigators. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial Am Heart J 146 2003 804 810
42. J.S. Hochman Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm Circulation 107 2003 2998 3002
43. J. Concato, N. Shah, and R.I. Horwitz Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 2000 1887 1892
44. R. Bluhm Some observations on observational research Perspect Biol Med 52 2009 252 263